Trial Profile
Effects of single-dose and 1-week duration escitalopram on a stop-change task in male volunteers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jan 2011
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Social phobia
- Focus Pharmacodynamics
- 11 Jan 2011 New trial record